CopilotIQ & Biofourmis Merge to Create AI-Driven Platform for In-Home Care

What You Should Know: 

CopilotIQ, a health tech company focused on improving the lives of older adults with chronic conditions, and Biofourmis, a global leader in technology-enabled home care solutions, have announced a strategic merger

– The combined company creates an AI-driven platform to deliver comprehensive in-home care across the entire care continuum, from pre-surgical optimization to acute, post-acute, and chronic care management. As part of this merger, investors from both businesses, including General Atlantic, Openspace Ventures, and Bessemer Venture Partners are investing into the combined business.

Addressing the Challenges of In-Home Care Delivery

Hospitals and payers face increasing pressure to deliver high-quality, cost-effective care in the home setting. However, managing multiple point solutions for different care needs creates complexity and fragmentation. This merger addresses these challenges by providing a single, integrated platform that streamlines in-home care delivery.

Benefits for Healthcare Organizations

The combined company offers several key advantages for healthcare organizations:

  • Comprehensive In-Home Care: Delivers a full spectrum of care, from pre-surgical optimization to chronic condition management, through a single vendor.
  • Unified Platform: Provides a “single pane of glass” solution for managing patients across the care continuum, simplifying technology integration and data management.
  • Enhanced Efficiency: Streamlines operations and reduces administrative burden by consolidating multiple point solutions into one platform.
  • Improved Patient Experience: Delivers a more coordinated and convenient care experience for patients.

“Our mission is to redefine the future of healthcare delivery, by extending care to the comfort of patients’ homes, and driving improved health outcomes, at the lowest possible cost to the system,” said David Koretz, CEO of CopilotIQ and Biofourmis, the newly combined entity. “This merger is a major step toward realizing our vision of transforming healthcare from reactive treatment to proactive prevention, and from generalized to deeply personalized, data-driven care.”